AXSM - Investor Alert: Bronstein Gewirtz & Grossman LLC Reminds Axsome Therapeutics Inc. (AXSM) Investors of Class Action and Encourages Shareholders to Contact the Firm | Benzinga

NEW YORK, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Axsome Therapeutics, Inc. ("Axsome" or "the Company") (NASDAQ:AXSM) and certain of its officers.

Class Definition:
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Axsome securities between May 10, 2021 and April 22, 2022, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/axsm.

Case Details:
The Complaint alleges that, throughout the Class Period, defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) the Company's development of AXS-07 was plagued ...

AXSM) Investors of Class Action and Encourages Shareholders to Contact the Firm>Full story available on Benzinga.com